Tumor sample characteristics
Sample no. | TNMa classification | UICC stage | SERPINE2 expression | ||
---|---|---|---|---|---|
1 | T2 | N1 | M0 | III | +++ |
2 | T3 | N1 | M1 | IVB | +++ |
3 | T3 | N1 | M0 | III | +++ |
4 | T1 | N0 | M0 | I | ++ |
5 | T2 | N1 | M0 | III | ++ |
6 | T2 | N0 | M0 | I | ++ |
7 | T2 | N0 | M0 | I | ++ |
8 | T2 | N0 | M0 | I | ++ |
9 | T3 | N1 | M0 | III | ++ |
10 | T3 | Nx | Mx | n.a. | ++ |
11 | T4 | N2 | M1 | IVB | ++ |
12 | n.a. | n.a. | ++ | ||
13 | n.a. | n.a. | ++ | ||
14 | n.a. | n.a. | ++ | ||
15 | n.a. | n.a. | ++ | ||
16 | T1 | N0 | M0 | I | + |
17 | T1 | N1 | M0 | III | + |
18 | T2 | N0 | M0 | I | + |
19 | T2 | N1 | M0 | III | + |
20 | T3 | NX | M1 | IVB | + |
21 | T3 | N1 | M0 | III | + |
22 | n.a. | n.a. | + | ||
23 | T2 | N0 | M0 | I | o |
24 | T2 | N0 | M0 | I | o |
25 | T3 | N0 | M1 | IVB | o |
26 | n.a. | n.a. | o | ||
27 | n.a. | n.a. | o |
a TNM, tumor-node-metastasis; n.a., not assessed; UICC, Union International Centre le Cancer.